Showing results (311-320 of 483) with videos related to
Sort By:
Pageof 49
British Journal of Cancer|August 22, 2023
Dissecting the pathogenic effects of smoking and its hallmarks in blood DNA methylation on colorectal cancer riskXuan Zhou, Qian Xiao, Fangyuan Jiang, et al.DNA Repair|February 8, 2011
An analysis of single nucleotide polymorphisms of 125 DNA repair genes in the Texas genome-wide association study of lung cancer with a replication for the XRCC4 SNPsHongping Yu, Hui Zhao, Li-E Wang, et al.Scientific Reports|December 3, 2015
Quantifying the heritability of glioma using genome-wide complex trait analysisBen Kinnersley, Jonathan S Mitchell, Konstantinos Gousias, et al.Blood|October 23, 2012
The clinical significance of NOTCH1 and SF3B1 mutations in the UK LRF CLL4 trialDavid G Oscier, Matthew J J Rose-Zerilli, Nils Winkelmann, et al.Nature Genetics|April 4, 2008
Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1Christopher I Amos, Xifeng Wu, Peter Broderick, et al.Blood|November 26, 2010
Autologous hematopoietic stem cell transplantation in chronic lymphocytic leukemia: results of European intergroup randomized trial comparing autografting versus observationMauricette Michallet, Peter Dreger, Laurent Sutton, et al.Molecular Carcinogenesis|February 3, 2017
Pathway-analysis of published genome-wide association studies of lung cancer: A potential role for the CYP4F3 locusJieyun Yin, Hongliang Liu, Zhensheng Liu, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 3, 2023
Exploring the Complex Relationship between Gut Microbiota and Risk of Colorectal Neoplasia Using Bidirectional Mendelian Randomization AnalysisWanxin Li, Xuan Zhou, Shuai Yuan, et al.Haematologica|March 4, 2014
ATM mutation rather than BIRC3 deletion and/or mutation predicts reduced survival in 11q-deleted chronic lymphocytic leukemia: data from the UK LRF CLL4 trialMatthew J J Rose-Zerilli, Jade Forster, Helen Parker, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 14, 2023
Daratumumab, Cyclophosphamide, Bortezomib, Lenalidomide, and Dexamethasone as Induction and Extended Consolidation Improves Outcome in Ultra-High-Risk Multiple MyelomaMartin F Kaiser, Andrew Hall, Katrina Walker, et al.Pageof 49